Login/Register
Shopping Cart

021-91002343

info@psvesta.com

  • فارسی
Guidelines
Guidelines
Introduction to diseases
Introduction to generic drugs
Introduction to pharmaceutical raw materials
Professional Articles
دسته بندی نشده
Requirements for Post-Approval Changes
Guide to preparing a DMF for APIs (Drug Master File)
Guide to preparing a DMF for APIs (Drug Master File)
Principles of preparing CTD and eCTD for drug registration in EMA and FDA
Stability Study Guideline based on ICH Q1

Latest content

Recent Articles

,

Requirements for Post-Approval Changes

psvesta
psvesta

8 months ago

,

Guide to preparing a DMF for APIs (Drug Master File)

psvesta
psvesta

8 months ago

,

Guide to preparing a DMF for APIs (Drug Master File)

psvesta
psvesta

8 months ago

,

Principles of preparing CTD and eCTD for drug registration in EMA and FDA

psvesta
psvesta

8 months ago

,

Stability Study Guideline based on ICH Q1

psvesta
psvesta

8 months ago

,

Multi-Sourcing Strategies to Reduce the Risk of Supply Delays

psvesta
psvesta

8 months ago

,

Physicochemical properties of excipients and their impact on API compatibility

psvesta
psvesta

8 months ago

,

Novel Excipients in Targeted Pharmaceuticals: A Revolution in Controlled Drug Release

psvesta
psvesta

8 months ago

  • Head office address:
  • No.28, Dr. Hesabi St, Fereshteh St, Tehran
  • Contact number:
  • Frequently used links
  • Most viewed articles
  • Categories
  • Our licenses
All rights belong to Pishro Salamat Vesta.
Whatsapp Instagram Telegram